Both genetic knockout and ASO mediated genetic knock-down studies clearly demonstrated that inhibition of CerS6 activity ameliorated metabolic diseases including insulin resistance, type 2 diabetes and obesity [Figure 2; (17, 18, 54)]. The gene discussed is CERS6; the disease is obesity due to melanocortin 4 receptor deficiency.